• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 2248
  • 506
  • 506
  • 506
  • 506
  • 506
  • 503
  • 279
  • 246
  • 192
  • 81
  • 56
  • 34
  • 22
  • 16
  • Tagged with
  • 6406
  • 1903
  • 1823
  • 1616
  • 1605
  • 1599
  • 1430
  • 1397
  • 685
  • 679
  • 498
  • 471
  • 461
  • 438
  • 423
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
221

The efficacy of cholinesterase inhibitors in Alzheimer's disease

Elshazali, Shazli 03 November 2023 (has links)
Alzheimer’s disease (AD) is a condition that afflicts millions of people around the world. Although the cause of AD is not completely understood, there are a number of hypotheses used to explain the mechanism that results in AD. Two distinct features of AD are senile plaques, which are made up of amyloid ß (Aß) peptide aggregates, and neurofibrillary tangles, which are made up of tau protein that has been hyperphosphorylated. According to the cholinergic hypothesis, there is a strong connection between Aß peptide accumulation and cholinergic disfunction. Reduced RNA processing has been attributed to cholinergic signaling disfunction resulting in the depletion of dendrites in cortical neurons, which has been shown to be increased in the latter stages of AD. One method to prevent acetylcholine (ACh) breakdown is via cholinesterase inhibitors (ChEIs). Using these inhibitors helps to keep ACh within the synapse and allows it to reach cholinergic neurons, thereby reducing cholinergic disfunction. This allows for individuals with AD to be treated with ChEIs, although they can cause various side effects.
222

Totarol as privileged natural product scaffold for antimalarial drug discovery

Gebregziabher, Mengisteab Bereketeab 22 August 2023 (has links) (PDF)
Malaria is one of the major killer diseases in many countries of southern Asia, South America and Africa. Today over 40% of the world population is at risk from malaria. It is the cause of 300 - 500 million infections and the death of more than 2 million people each year, most of whom are African children. Chloroquine has been the mainstream of malaria chemotherapy for nearly 60 years, but widespread resistance now limits its usefulness. A continuous effort to find alternative antimalarials to this drug has led to the discovery of other effective antimalarials of different types, such as aminoquinolines, artemisinins and nucleic acid inhibitors. However, the emergence of multi-drug resistant strains of the malaria parasite has caused a marked increase in malaria related deaths, and there is a continuous need to develop other new antimalarials. Natural products play an important role in the antimalarial drug discovery process. Quinine and derivatives of artemisinin, the two most important drugs available to treat sever falciparwn malaria, owe their origin to plants. Furthermore, several effective antimalarials have been synthesized using quinine as a model compound (e.g., aminoquinoline antimalarials) or are results of relatively simple chemical modifications on the parent natural products (e.g., artemisinin). In this thesis, the natural product scaffold “totarol", which possesses inherent antiplasmodial activity, was used to design and investigate the antiplasmodial activity of three different compound classes namely: Mannich bases, aminoalcohols and semicarbason derivatives. The aim was to incorporate important drug fragments into a natural product scaffold with intrinsic antiplasmodial activity, possibly leading to the discovery of new totarol based antimalarials. In the first class of compounds, a series of novel Mannich base derivatives of totarol have been designed and synthesized to mimic the known Mannich base antimalarials, such as amodiaquine, amopyroquine and other functionally related antimalarials. These compounds differed from each other in the nature of their amino methyl side chain which was varied to include different structural requirements. It was found that the secondary amine Mannich bases possessed better antiplasmodial activity against chloroquine sensitive strains of the parasite than the tertiary amine Mannich bases. However, none of the synthesized compounds were found to be as active as the parent compound (totarol). Based on the preliminary biological evaluations of the synthesized Mannich base derivatives, only selected primary amine derived /f-amino alcohols were synthesized in the second class of antimalarials. However, none of the synthesized compounds were found to possess significant antiplasmodial activity. This was consistent with previous findings whereby the presence of protonatable nitrogen at the beta position could be a necessary structural feature for high antiplasmodial activity with totarol-dcrived amino alcohols. The semicarbazone derivative of totarol also did not show any antiplasmodial activity. Furthermore, none of the 2-isopropylphenol derived Mannich bases showed significant antiplasmodial activity, suggesting the impo1iance of the diterpenoid backbone of totaro, in its inherent antiplasmodial activity.
223

Part I. The isolation and characterization of alkaloids of Caulophyllum thalictroides (L.) Michx. Part II. The isolation and characterization of alkaloid and neutral principles of Magnolia acuminata L.

Flom, Michael Stephen January 1971 (has links)
No description available.
224

Pharmacological Evaluation of a Putative M5 Antagonist at M1, M3 and M5 Receptors

Yan, Teng 29 January 2015 (has links)
No description available.
225

HEXIM1 IS AN INHIBITOR OF TWO TRANSCRIPTION FACTORS CRITICAL IN CANCER: THE ANDROGEN RECEPTOR AND HYPOXIA INDUCIBLE FACTOR-1 ALPHA

Yeh, I-Ju 09 February 2015 (has links)
No description available.
226

EXAMINING FLEXIBLE BIOLOGICAL STRUCTURES

Villarreal, Seth 13 February 2015 (has links)
No description available.
227

Microtubule Regulation in Cystic Fibrosis Pathophysiology

Rymut, Sharon Marie 03 September 2015 (has links)
No description available.
228

Characterization of Uracil DNA Glycosylase as a Therapeutic Target for Sensitization of Floxuridine in Cancer with P53 Mutation or Deficiency

Yan, Yan 07 September 2017 (has links)
No description available.
229

Preclinical Development of the Anti-cocaine Monoclonal Antibody h2E2 for the Treatment of Cocaine Addiction

Wetzel, Hanna N. January 2017 (has links)
No description available.
230

The Effect of Ethanol on Three Types of Ependymal Cilia in The Brain Lateral Ventricle

Al Omran , Alzahra J. January 2015 (has links)
No description available.

Page generated in 0.0547 seconds